載入...
Hepatitis C Disease Burden in the United States in the Era of Oral Direct-Acting Antivirals
Oral direct-acting antivirals (DAAs) represent a major advance in hepatitis C virus (HCV) treatment. Along with recent updates in HCV screening policy and expansions in insurance coverage, the treatment demand in the United States is changing rapidly. Our objective was to project the characteristics...
Na minha lista:
| 發表在: | Hepatology |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5035714/ https://ncbi.nlm.nih.gov/pubmed/27015107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28571 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|